Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network

Hee Sung Chae, Byoung Hoon You, Dong Yeop Kim, Hankyu Lee, Hyuk Wan Ko, Hyun Jeong Ko, Young Hee Choi, Sun Shim Choi, Young Won Chin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Whole-Transcriptome analysis and western blotting of sauchinone-Treated HepG2 cells demonstrated that sauchinone regulated genes relevant to cholesterol metabolism and synthesis. In particular, it was found that the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) was downregulated, and the expression of low density lipoprotein receptor (LDLR) was upregulated in sauchinone-Treated HepG2 cells. Consequently, LDL-cholesterol (LDL-C) uptake was increased. As a transcriptional regulator of PCSK9 expression, sterol regulatory elements binding protein-2 (SREBP-2) was proposed by transcriptome analysis and western blotting. Oral administration of sauchinone increased hepatic LDLR through PCSK9 inhibition in obese mice and showed the reduced serum LDL-C levels and downstream targets of SREBP-2. Thus, it is evident that sauchinone reduces hepatic steatosis by downregulating the expression of hepatic PCSK9 via SREBP-2.

Original languageEnglish
Article number6737
JournalScientific reports
Volume8
Issue number1
DOIs
Publication statusPublished - 2018 Dec 1

Fingerprint

Gene Regulatory Networks
Sterol Regulatory Element Binding Protein 2
Homeostasis
Cholesterol
Liver
LDL Receptors
Hep G2 Cells
Gene Expression Profiling
LDL Cholesterol
Down-Regulation
Western Blotting
Obese Mice
Oral Administration
Proprotein Convertase 9
sauchinone
Serum
Genes

All Science Journal Classification (ASJC) codes

  • General

Cite this

Chae, Hee Sung ; You, Byoung Hoon ; Kim, Dong Yeop ; Lee, Hankyu ; Ko, Hyuk Wan ; Ko, Hyun Jeong ; Choi, Young Hee ; Choi, Sun Shim ; Chin, Young Won. / Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network. In: Scientific reports. 2018 ; Vol. 8, No. 1.
@article{5c64ab686cef458eb35490e62e3ad32d,
title = "Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network",
abstract = "Whole-Transcriptome analysis and western blotting of sauchinone-Treated HepG2 cells demonstrated that sauchinone regulated genes relevant to cholesterol metabolism and synthesis. In particular, it was found that the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) was downregulated, and the expression of low density lipoprotein receptor (LDLR) was upregulated in sauchinone-Treated HepG2 cells. Consequently, LDL-cholesterol (LDL-C) uptake was increased. As a transcriptional regulator of PCSK9 expression, sterol regulatory elements binding protein-2 (SREBP-2) was proposed by transcriptome analysis and western blotting. Oral administration of sauchinone increased hepatic LDLR through PCSK9 inhibition in obese mice and showed the reduced serum LDL-C levels and downstream targets of SREBP-2. Thus, it is evident that sauchinone reduces hepatic steatosis by downregulating the expression of hepatic PCSK9 via SREBP-2.",
author = "Chae, {Hee Sung} and You, {Byoung Hoon} and Kim, {Dong Yeop} and Hankyu Lee and Ko, {Hyuk Wan} and Ko, {Hyun Jeong} and Choi, {Young Hee} and Choi, {Sun Shim} and Chin, {Young Won}",
year = "2018",
month = "12",
day = "1",
doi = "10.1038/s41598-018-24935-6",
language = "English",
volume = "8",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network. / Chae, Hee Sung; You, Byoung Hoon; Kim, Dong Yeop; Lee, Hankyu; Ko, Hyuk Wan; Ko, Hyun Jeong; Choi, Young Hee; Choi, Sun Shim; Chin, Young Won.

In: Scientific reports, Vol. 8, No. 1, 6737, 01.12.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network

AU - Chae, Hee Sung

AU - You, Byoung Hoon

AU - Kim, Dong Yeop

AU - Lee, Hankyu

AU - Ko, Hyuk Wan

AU - Ko, Hyun Jeong

AU - Choi, Young Hee

AU - Choi, Sun Shim

AU - Chin, Young Won

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Whole-Transcriptome analysis and western blotting of sauchinone-Treated HepG2 cells demonstrated that sauchinone regulated genes relevant to cholesterol metabolism and synthesis. In particular, it was found that the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) was downregulated, and the expression of low density lipoprotein receptor (LDLR) was upregulated in sauchinone-Treated HepG2 cells. Consequently, LDL-cholesterol (LDL-C) uptake was increased. As a transcriptional regulator of PCSK9 expression, sterol regulatory elements binding protein-2 (SREBP-2) was proposed by transcriptome analysis and western blotting. Oral administration of sauchinone increased hepatic LDLR through PCSK9 inhibition in obese mice and showed the reduced serum LDL-C levels and downstream targets of SREBP-2. Thus, it is evident that sauchinone reduces hepatic steatosis by downregulating the expression of hepatic PCSK9 via SREBP-2.

AB - Whole-Transcriptome analysis and western blotting of sauchinone-Treated HepG2 cells demonstrated that sauchinone regulated genes relevant to cholesterol metabolism and synthesis. In particular, it was found that the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) was downregulated, and the expression of low density lipoprotein receptor (LDLR) was upregulated in sauchinone-Treated HepG2 cells. Consequently, LDL-cholesterol (LDL-C) uptake was increased. As a transcriptional regulator of PCSK9 expression, sterol regulatory elements binding protein-2 (SREBP-2) was proposed by transcriptome analysis and western blotting. Oral administration of sauchinone increased hepatic LDLR through PCSK9 inhibition in obese mice and showed the reduced serum LDL-C levels and downstream targets of SREBP-2. Thus, it is evident that sauchinone reduces hepatic steatosis by downregulating the expression of hepatic PCSK9 via SREBP-2.

UR - http://www.scopus.com/inward/record.url?scp=85046283340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046283340&partnerID=8YFLogxK

U2 - 10.1038/s41598-018-24935-6

DO - 10.1038/s41598-018-24935-6

M3 - Article

C2 - 29712938

AN - SCOPUS:85046283340

VL - 8

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 6737

ER -